Evidence map›Paper›PMID 32309428›Full record

ArticleBioMed research international2020

Molecular Assessment of Resistance to Clarithromycin in

Jina Vazirzadeh, Jamal Falahi, Sharareh Moghim, Tahmineh Narimani, Rahmatollah Rafiei, Vajihe Karbasizadeh

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2025
    Review
  3. Article
  4. Diagnostic Methods for Helicobacter pylori.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Review
  5. Article
  6. Pathogens (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Genetic Diversity ofAdvanced biomedical research · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jina VazirzadehDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-6640-1005
Jamal FalahiHealth Clinical Sciences Research Center, Zahedan Branch, Islamic Azad University, Zahedan, Iran.ORCID https://orcid.org/0000-0001-5996-5884
Sharareh MoghimDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-7134-3145
Tahmineh NarimaniDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-2570-3592
Rahmatollah RafieiIslamic Azad University, Najafabad Branch, Iran.ORCID https://orcid.org/0000-0003-1670-1162
Vajihe KarbasizadehDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-3765-8151
Isfahan University of Medical Sciences · IRIslamic Azad University of Najafabad · IRIslamic Azad University, Zahedan Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aims

resultsBy using culturing,

conclusionAs presented in the study, the high prevalence of clarithromycin-resistant

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBiopsyClarithromycinCross-Sectional StudiesDrug Resistance, BacterialDyspepsiaEndoscopyFemaleHelicobacter InfectionsHelicobacter pyloriHumansIn Situ Hybridization, FluorescenceAnti-Bacterial AgentsClarithromycinRNA, Ribosomal, 23S

Identifiers

PMID32309428
PMCPMC7140143
OpenAlexW3013673416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.